Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

ClinicalTrials.gov ID: NCT00097344

Public ClinicalTrials.gov record NCT00097344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Study identification

NCT ID
NCT00097344
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Intarcia Therapeutics
Industry
Enrollment
842 participants

Conditions and interventions

Interventions

  • Atamestane Drug
  • Toremifene Drug
  • Letrozole Drug
  • Aromatase inhibition Drug
  • Estrogen receptor blocker Drug
  • Hormone therapy Procedure
  • Endocrine therapy Procedure
  • Antiestrogen therapy Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2004
Primary completion
Not listed
Completion
Jul 31, 2006
Last update posted
Aug 22, 2007

2004 – 2006

United States locations

U.S. sites
49
U.S. states
28
U.S. cities
49
Facility City State ZIP Site status
Research Site Mobile Alabama 36607
Research Site Tuscon Arizona 85704
Research Site Hot Springs Arkansas 71913
Research Site Fountain Valley California 92708
Research Site Greenbrae California 94904
Research Site Los Angeles California 90807
Research Site Poway California 92064
Research Site Greenwich Connecticut 06830
Research Site Jacksonville Florida 32209
Research Site Kissimmee Florida 34741
Research Site Miami Florida 33176
Research Site Ocala Florida 34474
Research Site Pembroke Pines Florida 33028
Research Site Tampa Florida 33607
Research Site Augusta Georgia 30901
Research Site Savannah Georgia 31405
Research Site Evansville Indiana 47713
Research Site New Albany Indiana 47150
Research Site Lenexa Kansas 66214
Research Site Louisville Kentucky 40207
Research Site Shreveport Louisiana 71105
Research Site Towson Maryland 21204
Research Site Detroit Michigan 48076
Research Site Flint Michigan 48532
Research Site Robbinsdale Minnesota 55422
Research Site St Louis Missouri 63128
Research Site Billings Montana 59101
Research Site Reno Nevada 89502
Research Site Cherry Hill New Jersey 08003
Research Site Newark New Jersey 07101
Research Site Fresh Meadows New York 11365
Research Site Valhalla New York 10595
Research Site Wooster Ohio 44691
Research Site Zanesville Ohio 43701
Research Site Philadelphia Pennsylvania 19146
Research Site West Reading Pennsylvania 19611
Research Site Columbia South Carolina 29203
Research Site Bristol Tennessee 37620
Research Site Memphis Tennessee 38120
Research Site Houston Texas 77024
Research Site Pasadena Texas 77504
Research Site Ogden Utah 84403
Research Site Chesapeake Virginia 23320
Research Site Danville Virginia 24541
Research Site Norfolk Virginia 23502
Research Site Lacey Washington 98503
Research Site Milwaukee Wisconsin 53215
Research Site Racine Wisconsin 53405
Research Site Rhinelander Wisconsin 54501

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00097344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 22, 2007 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00097344 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →